Page last updated: 2024-08-26

tuberostemonine and Non-alcoholic Fatty Liver Disease

tuberostemonine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, Y; Liu, S; Pan, T; Qi, X; Su, S; Sun, M; Zhou, L1

Other Studies

1 other study(ies) available for tuberostemonine and Non-alcoholic Fatty Liver Disease

ArticleYear
Tuberostemonine alleviates high-fat diet-induced obesity and hepatic steatosis by increasing energy consumption.
    Chemico-biological interactions, 2023, Aug-25, Volume: 381

    Topics: Alkaloids; Animals; Diet, High-Fat; Lipid Metabolism; Lipids; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity

2023